Published in Front Neurol on November 19, 2012
Ubiquitination regulates the neuroprotective function of the deubiquitinase ataxin-3 in vivo. J Biol Chem (2013) 0.88
The role of apolipoprotein E as a risk factor for an earlier age at onset for Machado-Joseph disease is doubtful. PLoS One (2014) 0.75
Wild type huntingtin toxicity in yeast: Implications for the role of amyloid cross-seeding in polyQ diseases. Prion (2016) 0.75
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
A haplotype map of the human genome. Nature (2005) 105.70
G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods (2007) 50.83
Trinucleotide repeat disorders. Annu Rev Neurosci (2007) 9.45
CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet (1994) 7.07
Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol (2004) 3.83
Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease. Neurology (2009) 2.04
Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol (1996) 1.77
Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. Proc Natl Acad Sci U S A (1997) 1.75
Correlation between CAG repeat length and clinical features in Machado-Joseph disease. Am J Hum Genet (1995) 1.67
CHIP suppresses polyglutamine aggregation and toxicity in vitro and in vivo. J Neurosci (2005) 1.57
CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation. J Biol Chem (2006) 1.55
Spinocerebellar ataxias in the Netherlands: prevalence and age at onset variance analysis. Neurology (2002) 1.40
In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogenesis. Neurobiol Dis (2008) 1.28
Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset. Brain (2005) 1.28
Age at onset variance analysis in spinocerebellar ataxias: a study in a Dutch-French cohort. Ann Neurol (2005) 1.26
Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease. Hum Mol Genet (2008) 1.23
Normal-repeat-length polyglutamine peptides accelerate aggregation nucleation and cytotoxicity of expanded polyglutamine proteins. Proc Natl Acad Sci U S A (2006) 1.21
Trinucleotide repeats and neurodegenerative disease. Brain (2004) 1.19
CAG repeat length in RAI1 is associated with age at onset variability in spinocerebellar ataxia type 2 (SCA2). Hum Mol Genet (2000) 1.09
New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado-Joseph disease). Curr Opin Neurol (2008) 1.06
A familial factor independent of CAG repeat length influences age at onset of Machado-Joseph disease. Am J Hum Genet (1996) 0.90
PolyQ-expanded ataxin-3 interacts with full-length ataxin-3 in a polyQ length-dependent manner. Neurosci Bull (2008) 0.80
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat Genet (2012) 2.63
SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J Clin Invest (2008) 2.42
Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Lancet Neurol (2013) 2.36
EEG features in idiopathic generalized epilepsy: clues to diagnosis. Epilepsia (2006) 2.23
Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification. Neurogenetics (2013) 2.11
Neuropsychological deficits associated with driving performance in Parkinson's and Alzheimer's disease. J Int Neuropsychol Soc (2005) 1.51
Genetic testing in the epilepsies--report of the ILAE Genetics Commission. Epilepsia (2010) 1.51
PNPLA6 mutations cause Boucher-Neuhauser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum. Brain (2013) 1.51
Muscle excitability abnormalities in Machado-Joseph disease. Arch Neurol (2008) 1.48
Redox modifier genes in amyotrophic lateral sclerosis in mice. J Clin Invest (2007) 1.46
Voxel-based morphometry in patients with idiopathic generalized epilepsies. Neuroimage (2006) 1.44
Chorea-acanthocytosis: report of two Brazilian cases. Mov Disord (2008) 1.44
Brain-derived neurotrophic factor gene val66met polymorphism and executive functioning in patients with bipolar disorder. Rev Bras Psiquiatr (2009) 1.41
Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7. Prog Neurobiol (2013) 1.40
RNAi-mediated gene silencing as a principle of action of venoms and poisons. Med Hypotheses (2007) 1.38
Subcortical band heterotopia (SBH) in males: clinical, imaging and genetic findings in comparison with females. Brain (2002) 1.37
Clinical and genetic analysis of 29 Brazilian patients with Huntington's disease-like phenotype. Arq Neuropsiquiatr (2011) 1.37
Expanding the phenotypes of the Pro56Ser VAPB mutation: proximal SMA with dysautonomia. Muscle Nerve (2006) 1.33
Role of ulnar nerve sonography in leprosy neuropathy with electrophysiologic correlation. J Ultrasound Med (2009) 1.33
Morphology of the cerebral cortex in preclinical Huntington's disease. Am J Psychiatry (2007) 1.32
Ancestral origin of the ATTCT repeat expansion in spinocerebellar ataxia type 10 (SCA10). PLoS One (2009) 1.23
Interrelationship of genetics and prenatal injury in the genesis of malformations of cortical development. Arch Neurol (2002) 1.15
Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia. Am J Hum Genet (2013) 1.15
Targeting focal adhesion kinase with small interfering RNA prevents and reverses load-induced cardiac hypertrophy in mice. Circ Res (2007) 1.13
Milestones in ataxia. Mov Disord (2011) 1.11
Clinician assessment of the driving competence of patients with dementia. J Am Geriatr Soc (2005) 1.09
Spinocerebellar ataxias in Brazil--frequencies and modulating effects of related genes. Cerebellum (2014) 1.09
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathol (2014) 1.08
Magnetic resonance imaging evidence of hippocampal sclerosis in asymptomatic, first-degree relatives of patients with familial mesial temporal lobe epilepsy. Arch Neurol (2002) 1.08
Shp2 negatively regulates growth in cardiomyocytes by controlling focal adhesion kinase/Src and mTOR pathways. Circ Res (2008) 1.07
Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression. Am J Med Genet A (2008) 1.05
Familial partial epilepsy with variable foci: clinical features and linkage to chromosome 22q12. Epilepsia (2004) 1.01
Damage to the superior gluteal nerve after direct lateral approach to the hip. Clin Orthop Relat Res (2007) 0.97
MRI volumetry shows increased anterior thalamic volumes in patients with absence seizures. Epilepsy Behav (2006) 0.95
Presymptomatic testing for neurogenetic diseases in Brazil: assessing who seeks and who follows through with testing. J Genet Couns (2011) 0.94
MicroRNA expression profile in murine central nervous system development. J Mol Neurosci (2008) 0.92
The APOE ε2 allele increases the risk of earlier age at onset in Machado-Joseph disease. Arch Neurol (2011) 0.91
Spinocerebellar ataxia type 3 (SCA3): thalamic neurodegeneration occurs independently from thalamic ataxin-3 immunopositive neuronal intranuclear inclusions. Brain Pathol (2006) 0.91
Axonal inclusions in spinocerebellar ataxia type 3. Acta Neuropathol (2010) 0.91
Novel mutations in the glucocerebrosidase gene of brazilian patients with Gaucher disease. JIMD Rep (2012) 0.90
Genetic interaction of GSH metabolic pathway genes in cystic fibrosis. BMC Med Genet (2013) 0.90
Magnetic resonance imaging abnormalities in familial temporal lobe epilepsy with auditory auras. Arch Neurol (2003) 0.90
Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12. Hum Mutat (2013) 0.90
Mutations, clinical findings and survival estimates in South American patients with X-linked adrenoleukodystrophy. PLoS One (2012) 0.89
[Enzyme replacement therapy for mucopolysaccharidoses I, II and VI: recommendations from a group of Brazilian F experts]. Rev Assoc Med Bras (2010) 0.89
Parkinson's disease and the heterozygous state for glucocerebrosidase mutations among Brazilians. Parkinsonism Relat Disord (2008) 0.89
Use of the frontal assessment battery in evaluating executive dysfunction in patients with Huntington's disease. J Neurol (2009) 0.89
A new candidate locus for bilateral perisylvian polymicrogyria mapped on chromosome Xq27. Am J Med Genet A (2008) 0.89
Progression of ataxia in patients with Machado-Joseph disease. Mov Disord (2009) 0.88
Clinical presentation of juvenile Huntington disease. Arq Neuropsiquiatr (2006) 0.88
Population analysis of the alpha hemoglobin stabilizing protein (AHSP) gene identifies sequence variants that alter expression and function. Am J Hematol (2008) 0.88
Chronic pain in Machado-Joseph disease: a frequent and disabling symptom. Arch Neurol (2007) 0.88
Volumetric brain changes in thalamus, corpus callosum and medial temporal structures: mild Alzheimer's disease compared with amnestic mild cognitive impairment. Dement Geriatr Cogn Disord (2012) 0.88
Caring for Machado-Joseph disease: current understanding and how to help patients. Parkinsonism Relat Disord (2009) 0.88
Ataxia rating scales--psychometric profiles, natural history and their application in clinical trials. Cerebellum (2012) 0.88
Concerns regarding lamotrigine and breast-feeding. Epilepsy Behav (2004) 0.87
X11alpha haploinsufficiency enhances Abeta amyloid deposition in Alzheimer's disease transgenic mice. Neurobiol Dis (2009) 0.87
New mutations in the ATM gene and clinical data of 25 AT patients. Neurogenetics (2011) 0.85
MicroRNA regulation and dysregulation in epilepsy. Front Cell Neurosci (2013) 0.85
Phosphoinositide-specific inositol polyphosphate 5-phosphatase IV inhibits inositide trisphosphate accumulation in hypothalamus and regulates food intake and body weight. Endocrinology (2006) 0.85
Brain stem and cerebellum volumetric analysis of Machado Joseph disease patients. Arq Neuropsiquiatr (2011) 0.85
Association of matrix metalloproteinase gene polymorphism with temporomandibular joint degeneration. Eur J Oral Sci (2011) 0.85
Nonmotor and extracerebellar features in Machado-Joseph disease: a review. Mov Disord (2013) 0.85
Clinical and biochemical study of 29 Brazilian patients with metachromatic leukodystrophy. J Inherit Metab Dis (2010) 0.84
Fluoro-Jade, but not Fluoro-Jade B, stains non-degenerating cells in brain and retina of embryonic and neonatal rats. Brain Res (2004) 0.84
Subcutaneous insulin-like growth factor-1 treatment in spinocerebellar ataxias: an open label clinical trial. Mov Disord (2010) 0.84
Defining new guidelines for screening the 22q11.2 deletion based on a clinical and dysmorphologic evaluation of 194 individuals and review of the literature. Eur J Pediatr (2013) 0.84
MicroRNAs: a new paradigm on molecular urological oncology. Urology (2010) 0.84
Experimental animal model and RNA interference: a promising association for bladder cancer research. World J Urol (2009) 0.84
A randomized, phase 2 clinical trial of lithium carbonate in Machado-Joseph disease. Mov Disord (2014) 0.84
Identification of miRNAs that modulate glucocerebrosidase activity in Gaucher disease cells. RNA Biol (2014) 0.83
Spinocerebellar ataxias: genotype-phenotype correlations in 104 Brazilian families. Clinics (Sao Paulo) (2012) 0.83
Dorsal root ganglionectomy for the diagnosis of sensory neuropathies. Surgical technique and results. Surg Neurol (2007) 0.83
Randomized controlled trial of atomoxetine for cognitive dysfunction in early Huntington disease. J Clin Psychopharmacol (2009) 0.83
Spinal cord atrophy correlates with disease duration and severity in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.83
Familial temporal lobe epilepsy with auditory features. Epilepsia (2005) 0.83
MEF2C silencing attenuates load-induced left ventricular hypertrophy by modulating mTOR/S6K pathway in mice. PLoS One (2009) 0.83
Early detection of leprosy by examination of household contacts, determination of serum anti-PGL-1 antibodies and consanguinity. Mem Inst Oswaldo Cruz (2011) 0.83
Outcome of surgical treatment in familial mesial temporal lobe epilepsy. Epilepsia (2003) 0.83
Preliminary Analysis of the Nonsynonymous Polymorphism rs17563 in BMP4 Gene in Brazilian Population Suggests Protection for Nonsyndromic Cleft Lip and Palate. Plast Surg Int (2012) 0.83
Evidence of thalamic dysfunction in Huntington disease by proton magnetic resonance spectroscopy. Mov Disord (2007) 0.83
Involvement of the central nervous system in the chronic form of Chagas' disease. J Neurol Sci (2008) 0.83
Correlation between quantitative EEG and MRI in idiopathic generalized epilepsy. Hum Brain Mapp (2010) 0.82
Swallowing dysfunction in hereditary neuropathy with liability to pressure palsies. Arq Neuropsiquiatr (2008) 0.82
A combined voxel-based morphometry and 1H-MRS study in patients with Friedreich's ataxia. J Neurol (2009) 0.82
Neocortical atrophy in Machado-Joseph disease: a longitudinal neuroimaging study. J Neuroimaging (2011) 0.82